Psychosocial Impact of Screening for Intracranial Aneurysms in Relatives With Familial Subarachnoid Hemorrhage

Background and Purpose— In families with ≥2 relatives with intracranial aneurysms (IAs), screening for IAs in asymptomatic first-degree relatives is often recommended. We assessed the long-term psychosocial impact of such screening. Methods— We identified all persons with IA (screen-positives) and matched them for age and sex with 2 controls without IA (screen-negatives) from hospital-based registers of familial IA. Persons underwent telephone interviews using questionnaires that covered the areas of psychosocial impact of screening, health-related quality of life (HRQoL), and mood. Data were compared between screen-positives and screen-negatives, and with reference populations. Results— Overall, 105 persons from 33 families with IA were included, of whom 35 were screen-positive and 70 were screen-negative. Of the screen-positives, 12 (44%) had reduced their work and 23 (66%) had experienced changes in ≥1 area of independence, self-esteem, future outlook, or personal relationships. In contrast, only 1 (2%) screen-negative person had stopped working and 12 (17%) others had experienced changes in their self-esteem, future outlook, or relationships. Screen-positives had lower HRQoL compared with screen-negatives and the reference population, whereas both screen groups had higher mean depression scores than the reference population. Despite these effects, only 3 persons regretted participating in screening. Conclusion— Although screening for IA is an important preventative strategy in high-risk individuals, it is associated with considerable psychosocial effects, both positive and negative. Greater awareness of such outcomes, and appropriate intervention where necessary, would appear to be a necessary component of IA screening programs.

[1]  T. Bird,et al.  Impact of presymptomatic genetic testing for hereditary ataxia and neuromuscular disorders. , 2004, Archives of neurology.

[2]  G. Rinkel,et al.  Repeated Screening for Intracranial Aneurysms in Familial Subarachnoid Hemorrhage , 2003, Stroke.

[3]  P. Bossuyt,et al.  Quality of Life, Anxiety, and Depression in Patients With an Untreated Intracranial Aneurysm or Arteriovenous Malformation , 2002, Stroke.

[4]  C Caroselli,et al.  Recommendations for the Management of Patients With Unruptured Intracranial Aneurysms: A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association , 2000, Stroke.

[5]  J. Lindholt,et al.  Psychological consequences of screening for abdominal aortic aneurysm and conservative treatment of small abdominal aortic aneurysms. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[6]  N. Aaronson,et al.  Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. , 1998, Journal of clinical epidemiology.

[7]  G. Rinkel,et al.  Initial and follow-up screening for aneurysms in families with familial subarachnoid hemorrhage , 1998, Neurology.

[8]  A. Algra,et al.  Quality of life in patients and partners after aneurysmal subarachnoid hemorrhage. , 1998, Stroke.

[9]  van den Wim Heuvel,et al.  Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands. , 1997, Journal of epidemiology and community health.

[10]  H. Ellis stroke , 1997, The Lancet.

[11]  Catherine A. Taylor,et al.  Long-term impact of Huntington disease linkage testing. , 1997, American journal of medical genetics.

[12]  J. Ormel,et al.  A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects , 1997, Psychological Medicine.

[13]  R. Brooks EuroQol: the current state of play. , 1996, Health policy.

[14]  M. Limburg,et al.  Subarachnoid haemorrhage in first and second degree relatives of patients with subarachnoid haemorrhage , 1995, BMJ.

[15]  G. Huston The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.